Nuvectis Pharma, Inc. NVCT
19.84 USD -0.45 (-2.22%)
Regular-session close
20.40 +0.56 +2.82%
After hours · Nov 19, 4:00 PM ET
19.74 Day range 20.48
5.77 52-week range 29.28
- YTD
- +162.78%
- 1 year
- +232.33%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -27.57M | -19.85M | -22.90M | -19.23M | -12.89M | |
| -26.44M | -19.00M | -22.26M | -19.09M | -12.89M | |
| -1.32 | -1.11 | -1.43 | -1.51 | -3.02 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 31.63M | 18.53M | 19.13M | 19.99M | 5.74M | |
| 31.71M | 18.61M | 19.18M | 20.41M | 6.66M | |
| 13.30M | 8.89M | 6.98M | 6.19M | 2.42M | |
| 18.41M | 9.71M | 12.20M | 14.22M | -11.01M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -16.01M | -12.25M | -15.95M | -13.56M | -9.50M | |
| 29.11M | 11.65M | 15.09M | 27.81M | 15.25M | |
| 13.10M | -593.00K | -867.00K | 14.25M | 5.74M |
